Literature DB >> 32814159

Implementing the international evidence-based guideline of assessment and management of polycystic ovary syndrome (PCOS): how to achieve weight loss in overweight and obese women with PCOS?

Sharon Lie Fong1, Annewiets Douma2, Johan Verhaeghe2.   

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women. Many of these women are overweight or obese. A minor weight loss of 5%-10% can significantly reduce reproductive, metabolic and psychological symptoms of PCOS and is recommended as a first step in the treatment of overweight or obese women with PCOS. Many weight loss programs have been proposed, but optimal methods on how to achieve the recommend weight loss are lacking. The aim of this systematic review was to generate practical tools for health professionals to guide women with PCOS towards a sustainable healthier lifestyle. PRISMA guidelines were used to conduct the systematic review. Eleven randomized controlled trials were found eligible for inclusion. Lifestyle modification strategies consisted of a diet, physical exercise, behavioural coaching or combined interventions. Mean weight loss ranged from +0.5 to -10.6 % of the initial body weight. However, the majority of the studies reported considerable drop-out rates varying between 12% and 47%. The heterogeneity of the described interventions and the high drop-out rates impede extrapolation of these results to daily clinical care. Hence, none of the described interventions seems superior to another in achieving substantial weight loss. In conclusion, the need for obtaining a healthier weight in overweight and obese women with PCOS is now well accepted. However, achieving this goal remains a challenge for both patients and healthcare providers. More research focusing on the multidisciplinary approach of lifestyle modification advice in daily practice is needed.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Diet; Lifestyle modification; PCOS; Weight loss

Year:  2020        PMID: 32814159     DOI: 10.1016/j.jogoh.2020.101894

Source DB:  PubMed          Journal:  J Gynecol Obstet Hum Reprod        ISSN: 2468-7847


  5 in total

Review 1.  Effects of Sitagliptin on Metabolic Indices and Hormone Levels in Polycystic Ovary Syndrome: a Meta-analysis of Randomized Controlled Trials.

Authors:  Lijuan Zhang; Airong Chen; Jing Lu; Liuliu Ren; Zelin Hu
Journal:  Reprod Sci       Date:  2022-08-12       Impact factor: 2.924

2.  Are Dietary Indices Associated with Polycystic Ovary Syndrome and Its Phenotypes? A Preliminary Study.

Authors:  Ana Cutillas-Tolín; Julián Jesús Arense-Gonzalo; Jaime Mendiola; Evdochia Adoamnei; Fuensanta Navarro-Lafuente; María Luisa Sánchez-Ferrer; María Teresa Prieto-Sánchez; Ana Carmona-Barnosi; Jesús Vioque; Alberto M Torres-Cantero
Journal:  Nutrients       Date:  2021-01-22       Impact factor: 5.717

3.  Metabolic health during a randomized controlled lifestyle intervention in women with PCOS.

Authors:  Alexandra Dietz de Loos; Geranne Jiskoot; Annemerle Beerthuizen; Jan Busschbach; Joop Laven
Journal:  Eur J Endocrinol       Date:  2021-11-30       Impact factor: 6.664

4.  Development and validation of a prediction model for depression in adolescents with polycystic ovary syndrome: A study protocol.

Authors:  Rui Ding; Heng Zhou; Xin Yan; Ying Liu; Yunmei Guo; Huiwen Tan; Xueting Wang; Yousha Wang; Lianhong Wang
Journal:  Front Psychiatry       Date:  2022-09-06       Impact factor: 5.435

Review 5.  Weight Management in Adolescents with Polycystic Ovary Syndrome.

Authors:  Jaime M Moore; Stephanie W Waldrop; Melanie Cree-Green
Journal:  Curr Obes Rep       Date:  2021-05-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.